TrivarX Clinches Approval for Proposed Protocol for Current Major Depressive Episode Trial Screening, Shares Jump 8%

MT NewswiresApr 28 01:37 ET

TrivarX Greenlit for US Trial Using Heartrate to Detect Depression in Veterans

The Market HeraldApr 27 22:56 ET

TrivarX Obtains Firm Commitments to Raise AU$2.3 Million via Placement; Shares Up 7%

MT NewswiresMar 17 00:04 ET

TrivarX Trial to Screen for Major Depressive Episode in Collaboration With US Department of Veteran Affairs

MT NewswiresMar 12 22:30 ET

TrivarX Ltd: Appendix 4D & Half-Year Financial Report to 31 December 2024

ASXFeb 27 23:11 ET · Announcements

ASX Small-Cap Stocks to Watch

MT NewswiresNov 6, 2024 18:44 ET

TrivarX Ltd: 2024 Annual Report

Sep 18, 2024 18:27 ET · Announcements

TrivarX Ltd: Notification under Listing Rule 4.3D

Sep 18, 2024 18:22 ET · Announcements

TrivarX Ltd: Appendix 4E - Preliminary Final Report

Aug 28, 2024 19:08 ET · Announcements

TrivarX Completes Phase 2 MEB-001 Algorithm Sleep Study for Depressive Episodes

Small CapsJul 9, 2024 23:28 ET

TrivarX Completes Phase 2 Sleep Signal Analysis for Current Major Depressive Episode Study; Shares Surge 11%

MT NewswiresJul 9, 2024 22:20 ET

TRIVARX LTD Issues 12 Million Unquoted Options

TipRanksJul 9, 2024 20:37 ET

TrivarX Ltd Aims for ASX Securities Quotation

TipRanksJul 9, 2024 20:18 ET

TrivarX Recruits 362 Patients for Phase-Two MEB-001 Sleep Signal Analysis Study

MT NewswiresJun 20, 2024 19:00 ET

TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%

MT NewswiresMay 1, 2024 21:00 ET

Trivarx Ltd Announces Major New Share Issue

TipRanksMay 1, 2024 19:47 ET

TrivarX Signs Collaboration With Northern Michigan University on Sleep Research

MT NewswiresFeb 8, 2024 20:15 ET

TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%

MT NewswiresFeb 7, 2024 21:39 ET

Over Half of Patients On Track for Completion in TrivarX's SAMDE Study

MT NewswiresFeb 7, 2024 05:32 ET